PPAR delta - CISMeF

Preferred Label : PPAR delta;

MeSH definition : A nuclear transcription factor. It is activated by PROSTACYCLIN.;

MeSH synonym : peroxisome proliferator activated receptor delta; peroxisome proliferator-activated receptor delta; ppard protein; ppardelta;

Wikipedia link : https://en.wikipedia.org/wiki/Peroxisome proliferator-activated receptor delta;

Is substance : O;

Details

Origin ID

D047494;

UMLS CUI

C0379275;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- (2-(2-(1-(2,4-dichlorophenylamino)-1-oxobutan-2-yl)-2,3,4,5-tetrahydro-1H-benzo(c)azepin-8-yloxy)acetic acid) [MeSH Supplementary Concept]
- (2-methyl-4-(5-methyl-2-(4-trifluoromethyl-phenyl)-2H-(1,2,3)triazol-4-ylmethylsulfanyl)phenoxy)acetic acid [MeSH Supplementary Concept]
- (4-(3,3-bis(4-bromophenyl)allylthio)-2-chlorophenoxy)acetic acid [MeSH Supplementary Concept]
- 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid [MeSH Supplementary Concept]
- 2-(2-methyl-4-((1-(6-(4-(trifluoromethyl)phenyl)-2-pyridinyl)pentyl)oxy)phenoxy)acetic acid [MeSH Supplementary Concept]
- 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid [MeSH Supplementary Concept]
- 2-(4-methoxy-3-((pyrene-1-carboxamido)methyl)benzyl)butanoic acid [MeSH Supplementary Concept]
- 3-(4-(3-(4-chloro-2-phenoxyphenoxy)butoxy)-2-ethylphenyl)propionic acid [MeSH Supplementary Concept]
- 4-(2,6-dimethyl-4-(4-trifluoromethoxyphenyl)piperazine-1-sulfonyl)indan-2-carboxylic acid [MeSH Supplementary Concept]
- 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide [MeSH Supplementary Concept]
- GW 610742 [MeSH Supplementary Concept]
- TIPP-204 [MeSH Supplementary Concept]
- ombuin-3-O-glucopyranoside [MeSH Supplementary Concept]
- phosphoiodyn A [MeSH Supplementary Concept]
- sipoglitazar [MeSH Supplementary Concept]
Record concept(s)
- PPAR delta [MeSH concept]
Related MeSH Supplementary Concept(s)
- PPARD protein, human [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients